Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:MRK)

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities

Business Wire 4 hours ago

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

Accesswire 20 hours ago

Merck Announces First-Quarter 2025 Dividend

Business Wire 1 day ago

Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints

Business Wire 2 days ago

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM)

Business Wire 6 days ago

Merck to Participate in the Jefferies London Healthcare Conference

Business Wire 7 days ago

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.

Business Wire 7 days ago

KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial

Business Wire 9 days ago

Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024

Business Wire 9 days ago
View More News ››

Opinion & Analysis (NYSE:MRK)

ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck

Streetwise Reports December 10, 2019

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

Streetwise Reports October 4, 2019

Possible 'best-in-class' alzheimer's drug candidate offers 'disruptive' potential

The Life Sciences Report September 21, 2017

Why the election is not as relevant to drug stocks as you might believe

The Life Sciences Report November 4, 2016

Circling the globe for uncommon biotech opportunities

The Life Sciences Report February 18, 2016

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of SeeThruEquity

Gail Dutton October 30, 2015
View More Opinion ››

Bullboard Posts (NYSE:MRK)

Merck (MRK) Q2 2024 Earnings Call Transcript

JUST IN: $MRK Merck (MRK) Q2 2024 Earnings Call Transcript2024-07-30 14:15:13 ET Image source: The Motley Fool. Merck (NYSE: MRK) Q2...
whytestocks - July 30, 2024

Merck beats earnings expectations (MRK)

601 Views Apr 25, 2024 CNBC's Joe Kernen reports on the company's quarterly earnings results. Merck beats earnings...
Betteryear2 - April 26, 2024

Merck Announces First-Quarter 2024 Financial Results (MRK)

April 25, 2024 06:30 AM Eastern Daylight Time RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the...
Betteryear2 - April 26, 2024

Merck to Participate in the Leerink Partners Global Biopharm

BREAKING NEWS: $MRK Merck to Participate in the Leerink Partners Global Biopharma Conference 2024Merck (NYSE: MRK), known as MSD outside...
whytestocks - March 4, 2024

Fear of recession overblown

https://mail.google.com/mail/u/0/#inbox/FMfcgzGpGdlhJzgczCNrqdzVqkFjpqbV
Goodtoreadthis1 - June 27, 2022

ONE DRUG PILL WIPES OUT COVID 19!

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021...
zeropointenergy - October 6, 2021
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »